Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma
<p>Abstract</p> <p>Background</p> <p>Melanoma incidence is on the rise and advanced melanoma carries an extremely poor prognosis. Treatment options, including chemotherapy and immunotherapy, are limited and offer low response rates and transient efficacy. Thus, identifi...
Main Authors: | Riker Adam I, Liu Suhu, Radfar Soroosh, Wang Yixiang, Khong Hung T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/8/14 |
Similar Items
-
Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma
by: Gabriela M Wiedemann, et al.
Published: (2019-02-01) -
Microphthalmia-associated transcription factor (MITF) – from Waardenburg syndrome genetics to melanoma therapy
by: Ivan Šamija, et al.
Published: (2010-11-01) -
Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma
by: Carla Abrahamian, et al.
Published: (2021-07-01) -
Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression
by: Taek-In Oh, et al.
Published: (2017-09-01) -
microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.
by: Nathalie Arts, et al.
Published: (2015-01-01)